Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Response: dexamethasone dose alters expression of NK activating receptors in vivo

Andy Hsu, Hang Quach, Tsin Tai, H. Miles Prince, Simon J. Harrison, Joseph A. Trapani, Mark J. Smyth, Paul J. Neeson, David S. Ritchie

Blood (2011) 118 (24): 6466–6468.

https://doi.org/10.1182/blood-2011-10-382291

Published: 2011

Journal Articles

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

Andy K. Hsu, Hang Quach, Tsin Tai, H. Miles Prince, Simon J. Harrison, Joseph A. Trapani, Mark J. Smyth, Paul Neeson, David S. Ritchie

Blood (2011) 117 (5): 1605–1613.

https://doi.org/10.1182/blood-2010-04-278432

Published: 2011

Includes: Supplemental data

Journal Articles

In Vitro Efficacy of Agonistic Antibody to TRAIL-R1 (Mapatumumab) and Low Dose Bortezomib in Multiple Myeloma

Paul Neeson, PhD, Karen Chen, Tsin Tai, MSc, Amanda Shin, Joanne Davis, PhD, H. Miles Prince, MD, David S. Ritchie, MD, PhD

Blood (2008) 112 (11): 5169.

https://doi.org/10.1182/blood.V112.11.5169.5169

Published: 2008

Journal Articles

Regulatory T Cells (Treg) Are Depressed in Patients with Relapsed/Refractory Multiple Myeloma (MM) and Increases towards Normal Range in Responding Patients Treated with Lenalidomide (LEN).

Hang Quach, MB, BS, FRACP, FRCPA, David Ritchie, MBChB, FRACP, FRCPA, PhD, Paul Neeson, PhD, Simon Harrison, MB, BS, MRCP, MRCPath, PhD, Tsin Tai, MSc, Kellie Tainton, BSc, Kevin Lynch, MB, BS, FFPM, Miles Prince, MB, BS, FRACP, FRCPA, MRACMA, MD

Blood (2008) 112 (11): 1696.

https://doi.org/10.1182/blood.V112.11.1696.1696

Published: 2008

Journal Articles

Gene-Modified CD8+ T Cells Undergo Functional Polarization to Effector and Central Memory Cells in Response to Antigen Exposure.

Paul Neeson, PhD, Amanda Shin, Tsin Tai, MSc, Karen Chen, Joanne Davis, Kellie Tainton, BSc, Phil Darcy, PhD, Michael H. Kershaw, Stefan Peinert, Preethi Guru, Simon Harrison, H. Miles Prince, D. Ritchie

Blood (2008) 112 (11): 1531.

https://doi.org/10.1182/blood.V112.11.1531.1531

Published: 2008

NARROW

Response: dexamethasone dose alters expression of NK activating receptors in vivo

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

In Vitro Efficacy of Agonistic Antibody to TRAIL-R1 (Mapatumumab) and Low Dose Bortezomib in Multiple Myeloma

Regulatory T Cells (Treg) Are Depressed in Patients with Relapsed/Refractory Multiple Myeloma (MM) and Increases towards Normal Range in Responding Patients Treated with Lenalidomide (LEN).

Gene-Modified CD8+ T Cells Undergo Functional Polarization to Effector and Central Memory Cells in Response to Antigen Exposure.

Email alerts

ASH Publications

American Society of Hematology

Response: dexamethasone dose alters expression of NK activating receptors in vivo

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

In Vitro Efficacy of Agonistic Antibody to TRAIL-R1 (Mapatumumab) and Low Dose Bortezomib in Multiple Myeloma

Regulatory T Cells (Treg) Are Depressed in Patients with Relapsed/Refractory Multiple Myeloma (MM) and Increases towards Normal Range in Responding Patients Treated with Lenalidomide (LEN).

Gene-Modified CD8+ T Cells Undergo Functional Polarization to Effector and Central Memory Cells in Response to Antigen Exposure.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only